Skip to main content
Peptide StackMuscle GrowthFat LossAnti-AgingEmerging EvidenceEducational · Not medical advice

Sermorelin + GHRP-2: GH Stimulation & Recovery

A synergistic combination of a GHRH analog (Sermorelin) and a ghrelin-mimetic GHRP (GHRP-2) that activates two distinct receptor pathways to amplify natural growth hormone release. Commonly researched for supporting body composition, recovery, and age-related GH decline.

2
Compounds
Emerging
Evidence Level
2
Research Refs
Muscle Growth
Primary Goal

Mechanism

Compound 1Performance

Sermorelin

GHRH analog that stimulates pulsatile GH release via pituitary GHRH receptors, providing the foundational signal for natural GH secretion.

+
Compound 2Performance

GHRP-2

Ghrelin-mimetic GHRP that activates GHS-R1a receptors, amplifying the GHRH signal and transiently suppressing somatostatin to maximize GH pulse amplitude.

Synergistic Effect

Dual-pathway activation

Sermorelin × GHRP-2

Safety Notes

Both peptides stimulate GH release through receptor-level signaling; neither contains exogenous GH. Individual GH and IGF-1 response varies; researchers typically assess baseline levels before use.

Research References

Per-component source only — no combination study exists

Emerging

Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency

BioDrugs 1998
Emerging

Effects of GHRP-2 on GH pulsatility and IGF-1 in healthy adults

J Clin Endocrinol Metab
Browse all →

⚠ Educational Use OnlyPeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.

Newsletter

The Peptide Research Digest

New providers, emerging stacks, and research developments — weekly.

No spam. Unsubscribe anytime. Privacy policy.